Advanced glycosylation endproduct-specific receptors on human and rat t-lymphocytes mediate synthesis of interferon γ: Role in tissue remodeling

Journal of Experimental Medicine

Volumn 178, Issue 6, 1993, Pages 2165-2172

  Imani, Farhad ^a   Horii, Yasuhiro ^a   Suthanthiran, Manikkam ^b   Skolnik, Edward Y ^a   Makita, Zenji ^a   Sharma, Vijay ^b   Sehajpal, Prabodh ^b   Vlassara, Helen ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b ROGOSIN INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; GAMMA INTERFERON; GLYCOLIPID; GLYCOPROTEIN; PHYTOHEMAGGLUTININ; POLYCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

AGING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FLOW CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LIPID STORAGE; LYMPHOCYTE ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; T LYMPHOCYTE SUBPOPULATION; TISSUE INJURY; TISSUE REGENERATION;

ANIMAL; BASE SEQUENCE; DNA PRIMERS; FLOW CYTOMETRY; GENE EXPRESSION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMAN; INTERFERON TYPE II; LIGANDS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MOLECULAR SEQUENCE DATA; MONOCYTES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; UP-REGULATION;

EID: 0027420670     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.178.6.2165     Document Type: Article

References (35)

1. Brownlee, M., A. Cerami, and H. Vlassara. 1988. Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med 318:1315.
2. Brownlee, M., H. Vlassara, and A. Cerami. 1987. The pathogenetic role of nonenzymatic glycosylation in diabetic complications. In Diabetic Complications: Scientific and Clinical Aspects. M.J.C. Crabbe, editor. Churchill Livingston, London. 94-139.
3. Bucala, R., H. Vlassara, and A. Cerami. 1992. Advanced glycosylation endproducts. In Post-Translational Modifications of Proteins. J.J. Harding, and M.J.C. Crabbe, editors. CRC Press Inc. 53-79.
4. Vlassara, H., M. Brownlee, and A. Cerami. 1985. High-aÉ&nity receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl. Acad. Sci. USA. 82:5588.
5. Vlassara, H., M. Brownlee, and A. Cerami. 1986. Novel macrophage receptor for glucose-modified protein is distinct from previously described scavenger receptors. J. Exp Med. 164:1301.
6. Radoff, S., H. Vlassara, and A. Cerami. 1988. Characterization of a solubilized cell surface binding protein on macrophages specific for protein modified nonenzymatically by advanced glycosylation endproducts. Arch. Biochem. Biopkys. 263:418.
7. Radoff, S., A. Cerami, and H. Vlassara. 1990. Isolation of surface binding protein specific for advanced glycosylation end-products from mouse macrophage-derived cell line RAW 264.7. Diabetes. 39:1510.
8. Yang, Z., Z. Makita, Y. Horii, S. Brunelle, A. Cerami, P. Se-hajpal, M. Suthanthiran, and H. Vlassara. 1991. Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins. J. Exp Med. 174:515.
9. Kirstein, M., C. Aston, R. Hintz, and H. Vlassara. 1992. Receptor-specific induction of insulin-like growth factor I (IGF-I) in human monocytes by advanced glycosylation endproduct-modified proteins. J. Clin. Invest. 90:439.
10. Doi, T., H. Vlassara, M. Kirstein, Y. Yamada, G.E. Striker, and L.J. Striker. 1992. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation endproducts is mediated via platelet-derived growth factor. Proc Natl. Acad. Set. USA. 89:2873.
11. Kirstein, M., J. Brett, S. Radoff, S. Ogawa, D. Stern, and H. Vlassara. 1990. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of PDGF: role in vascular disease of diabetes and aging. Proc Natl Acad. Sci. USA. 87:9010.
12. Vlassara, H., M. Brownlee, K.R. Manogue, C. Dinarello, and A. Pasagian. 1988. Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodeling. Science (Wash. DC). 240:1546.
13. Esposito, C., H. Gerlach, J. Brett, D. Stern, and H. Vlassara. 1989. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J. Exp Med. 170:1387.
14. Schmidt, A.M., M. Vianna, M. Gerlach, J. Brett, J. Ryan, and J. Kao. 1992. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chent. 256:14987.
15. Neeper, M., A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, Y.C.E. Pan, K. Ellis ton, D. Stern, and A. Shaw. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267:14998.
16. Skolnik, E.Y., Z. Yang, Z. Makita, S. Radoff, M. Kirstein, and H. Vlassara. 1991. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodeling and diabetic nephropathy. J. Exp Med. 174:931.
17. Kirstein, M., S. van Deventer, and H. Vlassara. 1990. Advanced glycosylation endproducts (AGE) binding to its specific receptor stimulates increase in EGF and EGF receptor mRNAs; role in tissue remodeling. J. Cell Biol. Suppl. 14E 89:2973.
18. Vlassara, H. Monocyte macrophage receptors for proteins modified by advanced glycation end products: role in normal tissue remodeling and in pathology. In Mononuclear Phagocytes Biology of Monocytes and Macrophages. 1992. Ralph van Furth, editor. Kluwer Academic Publishers, Dordrecht, The Netherlands. 193-201.
19. Libby, P., and G.K. Hansson. 1991. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 64:5.
20. Stemme, S., L. Rymo, and G.K. Hansson. 1991. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab. Invest. 65:654.
21. Stemme, S., J. Holm, and G.K. Hansson. 1992. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integin VLA-1. Arterioscler. Thromh 12:206.
22. Makita, Z., H. Vlassara, A. Cerami, and R. Bucala. 1992. Immunochemical detection of advanced glycosylation endproducts in viva J. Biol. Chem. 267:5133.
23. Chang, J.C.F., P.C. Ulrich, R. Bucala, and A. Cerami. 1985. Detection of an advanced glycosylation product bound to protein in situ. J. Biol. Chem. 260:7070.
24. Fraker, P.J., and J.C. Speck. 1978. Protein and cell membrane iodinations with a sparingly soluble chloramine, 1,3,4,6,-tetrachloro-3a, 6a-diphenylglycoluril. Biochem. Biopkys. Res. Commun. 80:849.
25. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand.J. Clin. Lab Invest. 21(Suppl. 97):77.
26. Kinkhabwala, M., P. Sehajpal, E. Skolnik, D. Smith, V.K. Sharma, H. Vlassara, A. Cerami, and M. Suthanthiran. 1990. A novel addition to the T cell repertory.J. Exp Med. 171:941.
27. Bradford, M. 1976. A rapid and sensitive assay for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
28. Scatchard, G. 1949. The attraction of proteins for small molecules and ions. Ann. NY. Acad. Sci. 51:660.
29. Stoolman, L.M., and S.D. Rosen. 1983. Possible role for cell-surface carbohydrate-binding molecules in lymphocyte recirculation. J. Cell Biol 96:722.
30. Vlassara, H., J. Valinsky, M. Brownlee, C. Cerami, S. Nishimoto, and A. Cerami. 1987. Advanced glycosykiion products on erythrocyte cell surface induce receptor mediated phagocytosis by macrophages; a model of turnover of aging cells. J. Exp Med. 166:539.
31. Smith, K.A. 1988. The interleukin-2 receptor. Adv. Immunol. 42:165.
32. Hansson, G.K., J. Holm, and L. Jonasson. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169.
33. van der Wal, A.C. 1989. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 61:166.
34. Hansson, G.K., L. Jonasson, J. Holm, M.K. Clowes, and A. Clowes. 1988. A gamma interferon regulates vascular smooth muscle proliferation and la expression in vivo and in vitro. Circ. Res. 63:712.
35. Hansson, G.K., M. Hellstrand, L. Rymo, L. Rubbia, and G. Gabbiani. 1989. Interferon-7 inhibits both proliferation and expression of differentiation-specific a-smooth muscle actin in arterial smooth muscle cells. J. Exp Med. 170:1595.